Prospective Oral Mucositis Audit: Oral Mucositis in Patients Receiving High-Dose Melphalan or BEAM Conditioning Chemotherapy—European Blood and Marrow Transplantation Mucositis Advisory Group

Abstract

Severe OM is more common in the transplantation setting than previously reported, justifying effective preventative and therapeutic measures.